KraneShares MSCI All China Hlth Care ETF (KURE)
14.30
+0.10
(+0.70%)
USD |
NYSEARCA |
Apr 25, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.65% | -0.12% | 45.81M | 7617.20 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.79% | 32.00% | -25.16M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index. The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Category Name | China Region |
| Category Index | MSCI China NR USD |
| Global Category Name | Greater China Equity |
| YCharts Categorization | China Equity |
| YCharts Benchmark | MSCI China Total Return (^MSCNTR) |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | KraneShares |
| Prospectus Benchmark Index | |
| MSCI China All Shares HC 10/40 NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
| Manager Tenure | |
| Jonathan Shelon | 5.67 yrs |
| James Maund | 4.22 yrs |
Performance Versus Category
As of April 25, 2024. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of April 25, 2024.
Basic Info
| Investment Strategy | |
| The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index. The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Category Name | China Region |
| Category Index | MSCI China NR USD |
| Global Category Name | Greater China Equity |
| YCharts Categorization | China Equity |
| YCharts Benchmark | MSCI China Total Return (^MSCNTR) |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | KraneShares |
| Prospectus Benchmark Index | |
| MSCI China All Shares HC 10/40 NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
| Manager Tenure | |
| Jonathan Shelon | 5.67 yrs |
| James Maund | 4.22 yrs |